Nuveen Asset Management, LLC Surface Oncology, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.42 - $3.15 $160,903 - $356,932	-113,312 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.65 - $5.08 $543 - $1,041	205 Added 0.18%	113,312 $326,000
Q4 2021 Feb 14, 2022	SELL	$4.73 - $7.9 $42,532 - $71,036	-8,992 Reduced 7.36%	113,107 $577,000
Q3 2021 Nov 12, 2021	BUY	$5.16 - $7.98 $118,592 - $183,404	22,983 Added 23.19%	122,099 $867,000
Q2 2021 Aug 16, 2021	BUY	$6.45 - $9.09 $639,298 - $900,964	99,116 New	99,116 $739,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.